Description

1-Piperidinecarbothioamide,3-(5,6-Dimethyl-1H-Benzimidazol-2-Yl)-n-(4-Methoxyphenyl)-(9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic structure combining piperidine and benzimidazole motifs. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents targeting specific biological pathways. It is primarily sought after by pharmaceutical R&D laboratories, biotechnology companies, and fine chemical manufacturers engaged in developing new drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel small-molecule drug candidates, particularly those targeting enzyme inhibition or receptor modulation.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop new therapeutic entities.
• Biochemical Tool Compound: Serves as a research probe in biochemical assays to study specific biological mechanisms and pathways.
• Fine Chemical Synthesis: Intermediate for the preparation of more complex, functionalized heterocyclic compounds in advanced organic synthesis.
• Contract Research & Development (CRO): Supplied to contract research organizations supporting drug discovery programs for global pharmaceutical clients.

Basic Information

Product Name	1-Piperidinecarbothioamide,3-(5,6-Dimethyl-1H-Benzimidazol-2-Yl)-n-(4-Methoxyphenyl)-(9Ci)
CAS No.	606089-37-6
Molecular Formula	C22H26N4OS
Molecular Weight	394.53 g/mol
Synonyms	3-(5,6-Dimethyl-1H-benzimidazol-2-yl)-N-(4-methoxyphenyl)-1-piperidinecarbothioamide; N-(4-Methoxyphenyl)-3-(5,6-dimethyl-1H-benzimidazol-2-yl)piperidine-1-carbothioamide; 1-Piperidinecarbothioamide, 3-(5,6-dimethyl-1H-benzimidazol-2-yl)-N-(4-methoxyphenyl)-; CAS 606089-37-6; 3-(5,6-Dimethyl-1H-benzimidazol-2-yl)-N-(4-methoxyphenyl)piperidine-1-carbothioamide
EINECS	Contact for details

Quality Control

Our 1-Piperidinecarbothioamide,3-(5,6-Dimethyl-1H-Benzimidazol-2-Yl)-n-(4-Methoxyphenyl)-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.